Clinical Role of Newly Developed ALBI and mALBI Grades for Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. The selection of therapeutic modalities and the prognosis of affected patients are well known to be dependent not only on the tumor burden but also on the hepatic reserve function. Antiviral treatments for chronic hepatitis relate...
Main Authors: | Atsushi Hiraoka, Takashi Kumada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/20/7178 |
Similar Items
-
Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade
by: Takashi Kumada, et al.
Published: (2020-07-01) -
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
by: Kazuomi Ueshima, et al.
Published: (2019-07-01) -
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker
by: Atsushi Hiraoka, et al.
Published: (2021-06-01) -
ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis
by: Theodora Oikonomou, et al.
Published: (2019-01-01) -
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
by: Hung-Wei Wang, et al.
Published: (2021-07-01)